Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Why is Guangdong Zhongsheng Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.67% and Operating profit at -207.00% over the last 5 years

The company has declared positive results in Mar'2025 after 6 consecutive negative quarters

RAW MATERIAL COST(Y) Fallen by -4.04% (YoY)
INVENTORY TURNOVER RATIO(HY) Highest at 2.58%
PRE-TAX PROFIT(Q) Highest at CNY 98.32 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 51.56%, its profits have fallen by -265%
At the current price, the company has a high dividend yield of 1.3

Market Beating Performance

The stock has generated a return of 51.56% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Guangdong Zhongsheng Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Guangdong Zhongsheng Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

-100.0%

1.20

50.61%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.67%

EBIT Growth (5y)

-207.00%

EBIT to Interest (avg)

1.98

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.15

Sales to Capital Employed (avg)

0.50

Tax Ratio

15.28%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.05%

ROE (avg)

6.83%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.27

EV to EBIT

-40.57

EV to EBITDA

-69.23

EV to Capital Employed

3.81

EV to Sales

5.09

PEG Ratio

Dividend Yield

1.32%

ROCE (Latest)

-9.39%

ROE (Latest)

-7.02%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.04% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.58%

PRE-TAX PROFIT(Q)

Highest at CNY 98.32 MM

NET PROFIT(Q)

Highest at CNY 81.82 MM

EPS(Q)

Highest at CNY 0.1

-12What is not working for the Company

NET PROFIT(HY)

At CNY -342.06 MM has Grown at -614.48%

ROCE(HY)

Lowest at -6.37%

INTEREST(Q)

At CNY 3.05 MM has Grown at 45.02%

Here's what is working for Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 98.32 MM has Grown at 222.71%

over average net sales of the previous four periods of CNY -80.12 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 81.82 MM has Grown at 218.23%

over average net sales of the previous four periods of CNY -69.2 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 98.32 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 81.82 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.1

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Highest at 2.58%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -4.04% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Interest

At CNY 3.05 MM has Grown at 45.02%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)